C
Christine Tedijanto
Researcher at Harvard University
Publications - 27
Citations - 3784
Christine Tedijanto is an academic researcher from Harvard University. The author has contributed to research in topics: Trachoma & Medicine. The author has an hindex of 9, co-authored 20 publications receiving 2617 citations. Previous affiliations of Christine Tedijanto include University of California, San Francisco & Foundation University, Islamabad.
Papers
More filters
Journal ArticleDOI
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.
TL;DR: Using existing data to build a deterministic model of multiyear interactions between existing coronaviruses, with a focus on the United States, is used to project the potential epidemic dynamics and pressures on critical care capacity over the next 5 years and projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave.
Posted ContentDOI
Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period
TL;DR: It is projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after an initial pandemic wave and the full range of plausible transmission scenarios are summarized.
Journal ArticleDOI
Practical considerations for measuring the effective reproductive number, Rt.
Katelyn M. Gostic,Lauren McGough,Edward B. Baskerville,Sam Abbott,Keya Joshi,Christine Tedijanto,Rebecca Kahn,Rene Niehus,James A. Hay,Pablo Martinez de Salazar,Joel Hellewell,Sophie Meakin,James D Munday,Nikos I Bosse,Katharine Sherrat,Robin N Thompson,Robin N Thompson,Laura F. White,Jana S. Huisman,Jérémie Scire,Jérémie Scire,Sebastian Bonhoeffer,Tanja Stadler,Tanja Stadler,Jacco Wallinga,Sebastian Funk,Marc Lipsitch,Sarah Cobey +27 more
TL;DR: The purpose of this document is to summarize challenges of estimation of the effective reproductive number Rt, illustrate them with examples from synthetic data, and, where possible, make recommendations.
Posted ContentDOI
Social distancing strategies for curbing the COVID-19 epidemic
TL;DR: It is assessed that one-time interventions will be insufficient to maintain COVID-19 prevalence within the critical care capacity of the United States and these measures may be necessary into 2022.
Journal ArticleDOI
Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora
TL;DR: It is estimated that pneumococcal conjugate vaccination programs result in nearly the same proportional reduction in total antibiotic exposures of Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli, despite the latter two organisms not being targeted by the vaccine.